Industry payments · Arthrex · Alabama · 2025

What did Arthrex pay clinicians in Alabama?

In 2025, Arthrex reported $7.3M in general payments to 57 Alabama clinicians across 493 payments, per CMS Open Payments data (excluding one-time buyouts). The typical (median) clinician on the list received $1K. Below: where the money went, and who it went to by specialty and city. No clinician is named on this page; the ranked, named list is what the app is for.

The breakdown

Where the money went.

General payments by category, and the products named on them. A payment is a disclosed relationship, not evidence a clinician uses any product.

Payment mix in Alabama

Royalty / license · 5 clinicians$7.0M

Speaker / services · 11 clinicians$121K

Consulting · 3 clinicians$67K

Travel & lodging · 48 clinicians$42K

Food & beverage · 52 clinicians$11K

Top products named on payments

Arthrex$7.1M

Product dollars span all payment types, and a payment naming several products counts toward each, so these rows don't sum to the total above.

Research: associated funding

Separate from the general payments above: $31K in research funding was associated with 2 Alabama clinicians named on studies as recipient or principal investigator. Research dollars fund the study, not the person.

The names behind these 57 clinicians are in the same public record. Prospect 811 puts them one search away: every Alabama clinician Arthrex paid, ranked by dollars, cross-linked to what each one actually bills Medicare, with specialty and phone number.

See who they paid →

Who gets paid

The specialties and cities.

Top specialties paid

Orthopaedic Surgery Physician28 clinicians

Sports Medicine (Orthopaedic Surgery) Physician7 clinicians

Orthopaedic Surgery of the Spine Physician5 clinicians

Student in an Organized Health Care Education/Training Program5 clinicians

Pediatric Nurse Practitioner2 clinicians

Where the paid clinicians are

Birmingham27 clinicians

Mobile5 clinicians

Phenix City4 clinicians

Montgomery3 clinicians

Hoover2 clinicians

Where these numbers come from. Everything on this page is computed from CMS's public Open Payments (Sunshine Act) data for program year 2025. Federal law requires manufacturers and group purchasing organizations to report payments and transfers of value to physicians and other covered clinicians; CMS publishes the records each year. A reported payment is a disclosed financial relationship required by law. It is not evidence of anything improper, and it says nothing about whether a clinician uses, prefers, or prescribes any product. Totals are general payments only and exclude acquisition buyouts and debt forgiveness (one-time events, not working relationships). Research dollars are shown separately as associated funding: money tied to a study on which a clinician is named as recipient or principal investigator. It funds the study, not the person. Product rows count a payment toward every product named on it, across all payment types, so product rows do not add up to the total. Clinicians whose federal enrollment record no longer lists a US practice state are not in state rollups. Prospect 811 organizes public data; it doesn't add to or alter it. Not affiliated with or endorsed by CMS. Full detail on the data page.

Industry relationships are public record. Your edge is knowing them.

Prospect 811 links Open Payments to Medicare billing for every clinician in your territory: who Arthrex pays, what those clinicians bill, and who takes no industry money at all. $79/month, no contract, 14-day refund.

Start prospecting →